https://sputnikglobe.com/20210202/critics-of-russias-sputnik-v-vaccine-went-silent-after-successful-phase-3-trials-rdif-says-1081959807.html
Critics of Russia’s Sputnik V Vaccine Went Silent After Successful Phase 3 Trials, RDIF Says
Critics of Russia’s Sputnik V Vaccine Went Silent After Successful Phase 3 Trials, RDIF Says
Sputnik International
MOSCOW (Sputnik) - Those who are doubtful of Russia’s Sputnik V vaccine now have no more reasoning for criticism as the phase 3 trials have proved the... 02.02.2021, Sputnik International
2021-02-02T14:50+0000
2021-02-02T14:50+0000
2021-02-02T15:03+0000
https://cdn1.img.sputnikglobe.com/img/07e4/08/11/1080192224_0:180:1024:760_1920x0_80_0_0_98da2434d9561a739ae1cc3cfa658e57.jpg
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2021
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
newsfeed, russian direct investment fund (rdif), lancet journal
newsfeed, russian direct investment fund (rdif), lancet journal
Critics of Russia’s Sputnik V Vaccine Went Silent After Successful Phase 3 Trials, RDIF Says
14:50 GMT 02.02.2021 (Updated: 15:03 GMT 02.02.2021) MOSCOW (Sputnik) - Those who are doubtful of Russia’s Sputnik V vaccine now have no more reasoning for criticism as the phase 3 trials have proved the vaccine's efficacy, as evidenced by a publication in the Lancet medical journal, CEO of Russian Direct Investment Fund (RDIF) Kirill Dmitriev said on Tuesday.
The Sputnik V vaccine is 91.6 percent efficient against symptomatic COVID-19, according to an interim analysis of the results of the phase 3 trials published earlier in the day in Lancet, one of the most reputable peer-reviewed medical journals.
2 February 2021, 12:30 GMT
"Many had doubts, but the article in Lancet provides the data and gives answers to all questions. It is very important, this is the most powerful watershed. We see that the critics have been going silent recently because there is nothing for them to pick on," Dmitriev said.
Sputnik V is the world's first coronavirus vaccine officially registered for emergency use in Russia on 11 August. In December, Russia launched large-scale coronavirus immunisation.
Russia produces the vaccine for domestic use on its own. It has also struck agreements with a number of foreign manufactures to produce doses for exports. The RDIF is leading efforts to promote the Russian vaccine abroad.
